Stokes Natalie, Kikucki Jacqueline
Department of Internal Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St. 100 Centrex, Philadelphia, PA, 19104, USA.
Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, USA.
Curr Treat Options Cardiovasc Med. 2018 Jun 19;20(7):57. doi: 10.1007/s11936-018-0652-9.
The goal of this review is to elucidate what is known about the science of maternal resuscitation and how treatment guidelines have developed to optimize management.
There is limited data on maternal cardiac arrest. Case reports are providing some insight into safety and efficacy of certain mechanisms of treatment, including use of extracorporeal membranous oxygenation and thrombolysis, for example. Data increasingly supports the preventability of a significant portion of maternal cardiac arrest, which remains the most important target for intervention. maternal cardiac arrest has increased in incidence over the past several decades but remains a rare event. In recent years, guidelines have emerged in attempt to standardize treatment, although research on best practice is scarce. Ultimately, future progress in targeting the rise in rate of cardiac arrest will come from large scale collaboration in data sharing and development of mechanisms to identify at risk patients to prevent arrest.
本综述的目的是阐明关于孕产妇复苏科学的已知情况,以及治疗指南如何发展以优化管理。
关于孕产妇心脏骤停的数据有限。病例报告为某些治疗机制的安全性和有效性提供了一些见解,例如体外膜肺氧合和溶栓的使用。越来越多的数据支持相当一部分孕产妇心脏骤停是可预防的,这仍然是最重要的干预目标。在过去几十年中,孕产妇心脏骤停的发病率有所上升,但仍然是罕见事件。近年来,已经出现了一些指南试图规范治疗,尽管关于最佳实践的研究很少。最终,针对心脏骤停发生率上升的未来进展将来自数据共享方面的大规模合作以及开发识别高危患者以预防心脏骤停的机制。